Question to the Department of Health and Social Care:
To ask Her Majesty's Government what recent discussions they have had with (1) the Medicines and Healthcare products Regulatory Agency, and (2) the National Institute for Health and Care Research, about which lessons from the success of COVID-19 trials could be applied to improve the (a) approval, and (b) set-up process, for dementia trials.